Verzenio is available as a 50 mg, 100 mg, 150 mg, and 200 mg oral tablet with recommended dosing of 150 mg twice daily when given in combination with fulvestrant and 200 mg twice daily when given alone. The average wholesale price (AWP) per tablet is $234.60. NPS is planning to review Verzenio for placement on the national formularies. For additional details on Verzenio, please view the FDAâs press release.
TUESDAY, Oct. 20 (HealthDay News) -- New research raises doubts about the long-held medical dogma that dangerous blood clots in the lungs, known as pulmonary emboli, originate from clots in the deep veins of the legs or other parts of the lower body, which then break up and travel up through the body.
An embolus is a particle that moves about in our blood vessels, either in the veins or arteries. Most emboli are composed of clotted blood cells. A blood clot is called a thrombus and a moving blood clot is called a thromboembolus. As an embolus moves through the body's blood vessels, it's likely to come to a passage it can't fit through. It lodges there, backing up blood behind it. The cells that normally get their blood supply via this passage are starved of oxygen (ischemia) and die. This condition is called an embolism.